767654
cis-Dichlorobis(dimethyl sulfoxide)platinum(II)
97%
Synonym(s):
cis-Dichlorobis(dimethylsulfoxido)platinum(II), Pt(DMSO)2Cl2
Sign Into View Organizational & Contract Pricing
All Photos(1)
About This Item
Empirical Formula (Hill Notation):
C4H12Cl2O2PtS2
CAS Number:
Molecular Weight:
422.25
MDL number:
UNSPSC Code:
12161600
PubChem Substance ID:
NACRES:
NA.22
Quality Level
Assay
97%
form
solid
reaction suitability
core: platinum
reagent type: catalyst
mp
218-224 °C
SMILES string
Cl[Pt]Cl.CS(C)=O.CS(C)=O
InChI
1S/2C2H6OS.2ClH.Pt/c2*1-4(2)3;;;/h2*1-2H3;2*1H;/q;;;;+2/p-2
InChI key
KDADQDWVKZJTDQ-UHFFFAOYSA-L
Related Categories
General description
cis-Dichlorobis(dimethyl sulfoxide)platinum(II) is a platinum complex used as a catalyst in various chemical reactions, including the methylation of polyfluorinated aryl imines and methane oxidation. It is identified as an effective C-F activation precatalyst.
Application
cis-Dichlorobis(dimethyl sulfoxide)platinum(II) can be used as a:
- Catalyst in the oleum-mediated (SO3-H2SO4) methane oxidation to form methyl bisulfate (MBS).
- Precursor in the synthesis of cyclometalated complexes.
Signal Word
Warning
Hazard Statements
Precautionary Statements
Hazard Classifications
Eye Irrit. 2 - Skin Irrit. 2 - STOT SE 3
Target Organs
Respiratory system
Storage Class Code
11 - Combustible Solids
WGK
WGK 3
Flash Point(F)
Not applicable
Flash Point(C)
Not applicable
Choose from one of the most recent versions:
Already Own This Product?
Find documentation for the products that you have recently purchased in the Document Library.
Customers Also Viewed
L Türkeri et al.
International urology and nephrology, 25(3), 259-263 (1993-01-01)
Traditional approaches for the treatment of locally advanced bladder tumours may not be sufficient enough. Neoadjuvant chemotherapy, a new modality, may be beneficial by enhancing the local and systemic control of the disease. The background of this new modality and
Osteosarcoma in adolescents and young adults: new developments and controversies. Thermal chemosensitization of cDDP-resistant cells.
A W Konings et al.
Cancer treatment and research, 62, 93-100 (1993-01-01)
A W Konings et al.
International journal of hyperthermia : the official journal of European Society for Hyperthermic Oncology, North American Hyperthermia Group, 9(4), 553-562 (1993-07-01)
cDDP-resistant Ehrlich ascites tumour (EAT) cells (ER cells) were tested for cellular content of total glutathione, heat sensitivity, cDDP sensitivity and synergistic effects of a combined treatment of heat and chemotherapy. In comparison with the non-resistant EAT cells (EN) the
J A Gondal et al.
European journal of cancer (Oxford, England : 1990), 29A(11), 1536-1542 (1993-01-01)
The systemic toxicity and efficacy of cisplatin (CDDP) were examined in vitro and in vivo. Procedures were performed before and after the antineoplastic agent was encapsulated into multilamellar liposomes (L-CDDP). In vitro cytotoxicity evaluation in L1210 murine leukaemia and NIH
H Nakagawa et al.
Journal of neuro-oncology, 16(1), 69-76 (1993-04-01)
Parenchymal brain tumors, which were metastases of primary lung cancer, were surgically removed from 25 patients. During the operation, patients were administered (intravenous or intracarotid) 100 mg/sq m of cis-diamminedichloroplatinum (CDDP) and postoperatively, they received intravenous CDDP at 3-month intervals
Our team of scientists has experience in all areas of research including Life Science, Material Science, Chemical Synthesis, Chromatography, Analytical and many others.
Contact Technical Service